Abstract

This review focuses on recent patents for the design and implementation of nanodevices to isolate and characterize single immune cells. Specifically, the most common categories of single cell assays were reviewed and new strategies were suggested to expand the capabilities of nanodevices further for the study of human immune disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call